|Awarded On||February 21, 2019|
|Title||Improving the Quality of Smoking Cessation and Shared Decision-Making for Lung Cancer Screening: A Cluster Randomized Trial|
|Award Mechanism||Individual Investigator Research Awards for Prevention and Early Detection|
|Institution/Organization||The University of Texas M.D. Anderson Cancer Center|
|Principal Investigator/Program Director||Robert J Volk|
|Cancer Sites||Lung and Bronchus|
*Pending contract negotiation
Smoking is the leading cause of lung cancer and 28,000 Texans die of lung cancer each year. Many of these smokers may be eligible for lung cancer screening (LCS), which can reduce the number of deaths from lung cancer. The Centers for Medicare & Medicaid Services now covers lung cancer screening, but requires that patients receive smoking cessation treatment and an opportunity to make a shared decision about LCS with a healthcare provider before they are referred for screening. Busy primary care providers are greatly challenged to meet these requirements, and new feasible strategies are needed to improve the quality of smoking cessation treatment and shared decision making for LCS. Currently...